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ABSTRACT 
 
A series of new (E)-N-(aryl)-N'-(1-(thiophen-2-yl)ethylidene)formohydrazides 2(a-g) and 1-(aryl)-3-(thiophen-2-yl)-
1H-pyrazole-4-carbaldehyde, 3(a-g)  were prepared by the controlled Vilsmeier-Haack reaction. The reaction of 
(E)-1-aryl-2-[(1-thiophen-2-yl)ethylidene]hydrazines 1(a-g) with Vilsmeier-Haack  reagent under different reaction 
conditions afforded the compounds 2(a-g) and  3(a-g)  in good yield. The synthesized compounds were 
characterized by IR, 1H NMR, 13C NMR, Mass spectral, x-ray diffraction studies and elemental analysis. The 
compounds were screened for their antimicrobial susceptibility against different bacterium and fungi species. 
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INTRODUCTION 
 
The transformation of a simple molecule to bioactive molecules of diverse biological applications is a worthwhile 
contribution in bioorganic chemistry. Formylation is an important process in organic synthesis. N-Formyl 
derivatives have been extensively used for the formylation of amines, amides, imines and alcohols [1]. Formyl 
derivatives are treated as useful synthons in organic and pharmaceutical chemistry; they have been extensively used 
as an intermediate in the synthesis of biologically potent molecules. They also exhibit remarkable biological 
activities, for instance, the formyl derivatives showed promising antimicrobial and antioxidant activities [2].   
 
Pyrazoles represent a key motif in heterocyclic chemistry and occupy a prime place in medicinal chemistry due to 
their competence to exhibit a wide range of pharmacological activities such as antimicrobial [3, 4], anticancer [5], 
anti-inflammatory [6], anticonvulsant [7], antioxidant [8], antipyretic activities [9]. Pyrazoles having a functional 
group like aldehyde or carboxylate C-4 position have shown promising antimicrobial properties [10].  
 
In view of the diverse synthetic and biological applications associated with the formyl derivatives, the task has been 
undertaken to synthesize new formyl derivatives and study their biological potency. 
 
EXPERIMENTAL SECTION 
 
We herein report the synthesis of series of novel (E)-N-(aryl)-N'-(1-(thiophen-2-yl)ethylidene)formohydrazides 2(a-
g) and 1-(aryl)-3-(thiophen-2-yl)-1H-pyrazole-4-carbaldehyde, 3(a-g) by Vilsmeier-Haack reaction. Initially, the 
required precursors (E)-1-aryl-2-[(1-thiophen-2-yl)ethylidene]hydrazines 1(a-g) were prepared by the reaction of 2-
acetyl thiophene and substituted phenylhydrazine hydrochlorides in the presence of sodium acetate in alcohol under 
reflux conditions.  
 
In a typical reaction, to a solution of E)-1-aryl-2-[(1-thiophen-2-yl)ethylidene]hydrazine 1a (0.2 mmol) in DMF, 
Vilsmeier-Haack reagent was added drop-wise. The reaction mixture was stirred at 50–55 °C for 6 hrs. After 
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completion of the reaction, the mixture was neutralized with sodium bicarbonate in ice cold water. The resulting 
solid was recrystallized from ethanol to get (E)-N-(aryl)-N'-(1-(thiophen-2-yl)ethylidene)formohydrazide 2a in 84% 
yield. However, with little excess of DMF and POCl3, and at 65–70 °C for 6 hrs the reaction yielded 1-(4-
methoxyphenyl)-3-(thiophen-2-yl)-1H-pyrazole-4-carbaldehyde 3a in 92% yield. The reaction pathway is depicted 
in scheme-1. 
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a) R1= H; R2 = H; R3 = OCH3;
b) R1= H; R2 = OCH3; R
3 = OCH3;
c) R1= H; R2 = H; R3 = CH3;
d) R1= H; R2 = H; R3 = H;
e) R1= H; R2 = H; R3 = Cl;
f) R1= H; R2 = H; R3 = F;
g) R1= H; R2 = H; R3 = NO2;
Scheme-1: Synthetic route for formohydrazides and formyl pyrazoles
 
 
Antimicrobial activity of the synthesized compounds was done by paper disc diffusion method [11, 12]. The stock 
solution of the synthesized compounds were prepared by dissolving in minimum quantity of methanol and then 
diluted with water. The test compounds 2(a-g) and 3(a-g) at the concentration of 50 µg/mL concentrations in the 
nutrient agar media were screened for their antibacterial activity. The bacteria species Escherichia coli, Salmonella 
typhimurium, Bacillus substilis and the fungi species Aspergillus niger, Aspergillus flavus and Fusarium oxysporium 
were used as strains The antibiotics streptomycin and nystatin were used as standard drugs against bacteria and fungi 
organisms respectively.  
 
EXPERIMENTAL SECTION 
 
Melting points were determined by open capillary method and are uncorrected. IR spectra were recorded on a Nujol 
mull on Shimadzu 8300 spectrometer. 1H NMR and 13C NMR spectra were recorded on Agilent-NMR 400 MHz and 
100 MHz spectrophotometer respectively in CDCl3 with TMS as an internal standard. The Chemical shifts are 
expressed in δ ppm. Mass spectra were obtained on Mass Lynx SCN781 spectrophotomer TOF mode. Elemental 
analysis was performed on a Thermo Finnigan Flash EA 1112 CHN analyzer. Chromatographic separations were 
carried out on silica gel (70-230 mesh, Merck) column using hexane: ethyl acetate (6:2) as eluent.  
 
General procedure for the synthesis of (E)-N-(Aryl)-N'-(1-(thiophen-2-yl)ethylidene)formohydrazides, 2(a-g): 
To a solution of (E)-1-aryl-2-[(1-thiophen-2-yl)ethylidene]hydrazine 1(a-g) (0.2 mmol) in DMF, Vilsmeier-Haack 
reagent prepared by drop-wise addition of POCl3 (1.5 ml) in ice cooled DMF (5 ml) was added slowly with swirling. 
The mixture was stirred at 50–55 °C for 6 h. The progress of the reaction was monitored by TLC. After completion 
of the reaction, the mixture was poured into ice cold water and then neutralized with sodium bicarbonate. The solid 
separated was filtered, washed thoroughly with ice cold water. The resulting solid was recrystallized from ethanol 
afforded the products 1(a-g) in 76-88%. 
 
General procedure for the synthesis of 1-(4-Methoxyphenyl)-3-(thiophen-2-yl)-1H-pyrazole-4-carbaldehyde, 
3(a-g): To a solution of (E)-1-aryl-2-[(1-thiophen-2-yl)ethylidene]hydrazine 1(a-g) (0.2 mmol) in DMF, Vilsmeier-
Haack reagent prepared by drop-wise addition of POCl3 (3.0 ml) in ice cooled DMF (10 ml) was added slowly with 
swirling. The mixture was stirred at 65–70 °C for 6 h. The progress of the reaction was monitored by TLC. After 
completion of the reaction, the mixture was poured into ice cold water and then neutralized with sodium 
bicarbonate. The solid separated was filtered, washed thoroughly with ice cold water. The resulting solid was 
recrystallized from ethanol afforded the products 3(a-g) in 80-94%. 
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RESULTS AND DISCUSSION 
 
 (E)-N-(4-Methoxyphenyl)-N'-(1-(thiophen-2-yl)ethylidene)formohydrazide, 2a: Obtained from (E)-1-(4-
methoxyphenyl)-2-(1-(thiophen-2-yl)ethylidene)hydrazine (1b), as white solid in 80% yield, mp 121-123 ºC. IR 
(Nujol, γ cm-1): 1735 (s) (C=O str). 1H NMR (CDCl3): δ 2.32 (s, 3H, CH3), 3.88 (s, 3H, OCH3), 7.02 (dd, 2H), 7.18-
7.42 (m, 3H, 5m ring), 7.55 (d, 2H, Ar-H), 9.36 (s, 1H, -CHO). 13C NMR (CDCl3): δ 14.66 (1C, CH3), 55.60 (1C, 
OCH3), 115.20 (2C), 124.60 (1C), 125.44 (1C), 125.80 (1C), 127.02 (1C), 127.36 (2C), 130.18 (1C), 155.10 (1C, 
C=N), 157.20 (1C), 166.54 (1C, C=O). MS (m/z): 274 (M+, 22), 246 (45), 125 (52), 121 (100). Anal. Calcd. for 
C14H14N2O2S: C, 61.29; H, 5.14; N, 10.21%; Found: C, 61.21; H, 5.22; N, 10.26%. 
 
(E)-N-(3,4-Dimethoxyphenyl)-N'-(1-(thiophen-2-yl)ethylidene)formohydrazide, 2b: Obtained from (E)-1-(3,4-
dimethoxyphenyl)-2-(1-(thiophen-2-yl)ethylidene)hydrazine (1b), as white crystalline solid in 78% yield, mp 100-
103 ºC. IR (Nujol, γ cm-1):  1728 (s) (C=O str).  1H NMR (CDCl3): δ 2.421 (s, 3H, CH3), 3.853 (s, 6H, OCH3), 
7.026-7.674 (m, 6H, Ar-H, 5m ring), 9.403 (s, 1H, -CHO). 13C NMR (CDCl3): δ 14.84 (1C, CH3), 55.85 (2C, 
OCH3), 105.11 (1C), 113.40 (1C), 120.32 (1C), 124.20 (1C), 125.08 (1C), 126.96 (1C), 127.44 (1C), 132.20 (1C), 
155.36 (1C, C=N), 144.10 (1C), 149.33 (1C), 165.03 (1C, C=O). MS (m/z): 304 (M+, 18), 176 (38), 125 (36), 121 
(100). Anal. Calcd. for C15H16N2O3S: C, 59.19; H, 5.30; N, 9.20%; Found: C, 59.11; H, 5.18; N, 9.28%. 
 
(E)-N'-(1-(Thiophen-2-yl)ethylidene)-N-(p-tolyl)formohydrazide, 2c: Obtained from (E)-1-(1-(thiophen-2-
yl)ethylidene)-2-(p-tolyl)hydrazine (1c) as white crystalline solid in 79% yield, mp 97-98 ºC. IR (Nujol, γ cm-1):  
1730 (s) (C=O str). 1H NMR (CDCl3): δ 2.302 (s, 3H, CH3), 7.326-7.500 (m, 3H, 5m ring), 7.623 (dd, 2H), 7.755 
(dd, 2H), 9.442 (s, 1H, -CHO). 13C NMR (CDCl3): δ 14.90 (1C, CH3), 22.10 (1C, CH3), 124.86 (1C), 125.34 (1C), 
125.82 (2C), 127.18 (1C), 127.48 (1C), 129.90 (2C), 133.60 (1C), 135.28 (1C), 154.88 (1C, C=N), 163.93 (1C, 
C=O). MS (m/z): 258 (M+, 22), 230 (41), 125 (23), 121 (100). Anal. Calcd. for C14H14N2OS: C, 65.09; H, 5.46; N, 
10.84%; Found: C, 65.00; H, 5.41; N, 10.96%. 
 
(E)-N-phenyl-N'-(1-(thiophen-2-yl)ethylidene)formohydrazide, 2d: Obtained from 1-phenyl-2-(1-(thiophen-2-
yl)ethylidene)hydrazine (1d) [13].  
 
(E)-N-(4-chlorophenyl)-N'-(1-(thiophen-2-yl)ethylidene)formohydrazide, 2e: Obtained from (E)-1-(4-
chlorophenyl)-2-(1-(thiophen-2-yl)ethylidene)hydrazine (1e), as white crystalline solid in 78% yield, mp 105-107 
ºC. IR (Nujol, γ cm-1):  1733 (s) (C=O str). 1H NMR (CDCl3): δ 2.181 (s, 3H, CH3), 7.361-7.629 (m, 3H), 7.707 (dd, 
2H), 7.832 (dd, 2H), 9.306 (s, 1H, -CHO). 13C NMR (CDCl3): δ 15.06 (1C, CH3), 124.40 (1C), 125.14 (1C), 126.12 
(2C), 127.26 (1C), 127.92 (1C), 129.42 (2C), 133.14 (1C), 134.20 (1C), 155.28 (1C, C=N), 164.90 (1C, C=O). MS 
(m/z): 280 (M+, 37Cl, 09), 278 (M+, 35Cl, 31), 250 (41), 125 (50), 125 (100). Anal. Calcd. for C13H11ClN2OS: C, 
56.01; H, 3.98; N, 10.05%; Found: C, 56.12; H, 3.92; N, 10.10%. 
 
(E)-N-(4-fluorophenyl)-N'-(1-(thiophen-2-yl)ethylidene)formohydrazide, 2f: Obtained from (E)-1-(4-
fluorophenyl)-2-(1-(thiophen-2-yl)ethylidene)hydrazine (1f), as white crystalline solid in 80% yield, mp 131-132 ºC. 
IR (Nujol, γ cm-1):  1720 (s) (C=O str). 1H NMR (CDCl3): δ 2.380 (s, 3H, CH3), 7.460-7.722 (m, 3H, 5m ring), 7.804 
(dd, 2H), 8.089 (dd, 2H), 9.348 (s, 1H, -CHO). 13C NMR (CDCl3): δ 14.96 (1C, CH3), 116.40 (2C), 123.26 (2C), 
124.52 (1C), 125.66 (1C), 127.50 (1C), 127.86 (1C), 133.12 (1C), 155.18 (1C, C=N), 160.10 (1C), 165.30 (1C, 
C=O). Anal. Calcd. for C13H11FN2OS: C, 59.53; H, 4.23; N, 10.68%; Found: C, 59.41; H, 4.20; N, 10.62%. 
 
(E)-N-(4-nitrophenyl)-N'-(1-(thiophen-2-yl)ethylidene)formohydrazide, 2g: Obtained from (E)-1-(4-nitrophenyl)-
2-(1-(thiophen-2-yl)ethylidene)hydrazine (1g), as white solid in 86% yield, mp 109-112 ºC. IR (Nujol, γ cm-1):  
1738 (s) (C=O str). 1H NMR (CDCl3): δ 2.368 (s, 3H, CH3), 7.438-7.622 (m, 3H, 5m ring), 7.824 (dd, 2H), 8.12 (dd, 
2H), 9.189 (s, 1H, -CHO). Anal. Calcd. for C13H11N3O3S: C, 53.97; H, 3.83; N, 14.52%; Found: C, 53.88; H, 3.91; 
N, 14.42%. 
 
The structure proofs of the synthesized new compounds were provided by IR, 1H NMR, 13C NMR, Mass spectral 
studies, X-ray diffraction studies and elemental analysis. In IR spectra, the compounds 2(a-g) showed a strong IR 
absorption bands in the region 1738-1720 cm-1 for aldehydic C=O stretching. The absorption bands expected due to 
N-H str of =N-N-H- group of the precursors hydrazones in the region 3280-3150 cm-1 were found absent. In 1H 
NMR spectra, compounds showed a singlet in the region δ 9.248-9.426 ppm. further they showed the signals due to 
substituent and aromatic protons at the expected region. 
 
In 13C NMR, the compounds 2(a-g) showed signals due to C=N function carbon atom in the region δ 154.00-156.00 
ppm, and for carbonyl carbon in the region δ 163.00-166.00 ppm. Further all compounds showed the signals due to 
substituent carbons, aromatic carbons, and thiophene ring carbons in the expected region. All new compounds gave 
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significantly stable molecular ion peaks with a relative abundance ranging from 12-100%. The structure of the one 
of the synthesized compounds was confirmed by single crystal X-ray diffraction studies [13]. The satisfactorily 
elemental analysis further supports structure of the products. 
 
1-(4-Methoxyphenyl)-3-(thiophen-2-yl)-1H-pyrazole-4-carbaldehyde, 3a: Obtained from (E)-1-(4-
methoxyphenyl)-2-(1-(thiophen-2-yl)ethylidene)hydrazine (1a), as white solid in 86% yield, mp 143-144 ºC. IR 
(Nujol, γ cm-1): 1726 (s) (C=O str), 1616 (m) (C=N str). 1H NMR (CDCl3): δ 3.845 (s, 3H, OCH3), 6.966 (d, 2H, Ar-
H), 7.385-7.435 (m, 3H, 5m ring), 7.505 (d, 2H, Ar-H), 8.283 (s, 1H, C5-H), 9.966 (s, 1H, CHO). 13C NMR 
(CDCl3): δ 55.60 (1C, OCH3), 112.46 (2C), 114.24 (1C, C-4), 114.88 (2C), 127.80 (1C), 128.32 (1C), 129.12 (1C), 
131.30 (1C, C-5), 133.12 (1C), 136.64 (1C, C-3), 139.04 (1C), 157.30 (1C), 184.76 (1C, C=O). MS: m/z 285 (MH+, 
14), 284 (M+, 36), 256 (44), 135 (51), 121 (100), 109 (33). Anal. Calcd. for C15H12N2O2S: C, 63.36; H, 4.25; N, 
9.85%; Found C, 63.27; H, 4.12; N, 9.88%. 
 
1-(3,4-Dimethoxyphenyl)-3-(thiophen-2-yl)-1H-pyrazole-4-carbaldehyde, 3b: Obtained from (E)-1-(3,4-
dimethoxyphenyl)-2-(1-(thiophen-2-yl)ethylidene)hydrazine (1b), as white solid in 92% yield, mp 133-136 ºC. IR 
(Nujol, γ cm-1): 1734 (s) (C=O str), 1612 (m) (C=N str).  1H NMR (CDCl3): δ 3.865 (s, 6H, OCH3), 6.963-7.486 (m, 
6H, Ar-H, 5m ring), 8.408 (s, 1H, C5-H), 10.006 (s, 1H, CHO). 13C NMR (CDCl3): δ 55.80 (2C, OCH3), 100.14 
(1C), 103.20 (1C), 113.88 (1C, C-4), 118.12 (1C), 127.40 (1C), 128.10 (1C), 128.84 (1C), 130.24 (1C, C-5), 134.44 
(1C), 136.80 (1C, C-3), 139.10 (1C), 149.10 (1C), 150.20 (1C), 185.20 (1C, C=O). MS: m/z 315 (MH+, 14), 314 
(M+, 30), 286 (41), 135 (50), 151 (100), 109 (33). Anal. Calcd. for C16H14N2O3S: C, 61.13; H, 4.49; N, 8.91%; 
Found 61.05; H, 4.57; N, 8.84%. 
 
1-(4-Methylphenyl)-3-(thiophen-2-yl)-1H-pyrazole-4-carbaldehyde, 3c: Obtained from (E)-1-(1-(thiophen-2-
yl)ethylidene)-2-(p-tolyl)hydrazine (1c), as white solid in 86% yield, mp 106-108 ºC. IR (Nujol, γ cm-1): 1728 (s) 
(C=O str), 1618 (m) (C=N str). 1H NMR (CDCl3): δ 2.326 (s, 3H, CH3), 7.066-7.237 (m, 3H, 5m ring), 7.369 (d, 2H, 
Ar-H), 7.480 (d, 2H, Ar-H), 8.342 (s, 1H, C5-H), 9.902 (s, 1H, CHO). 13C NMR (CDCl3): δ 21.84 (1C, CH3), 114.66 
(1C, C-4), 118.34 (2C), 127.60 (1C), 128.00 (1C), 128.66 (2C), 128.90 (1C), 131.96 (1C, C-5), 135.50 (1C), 136.22 
(1C, C-3), 136.90 (1C), 138.20 (1C), 185.88 (1C, C=O). MS: m/z 269 (MH+, 11), 268 (M+, 28), 240 (49), 135 (42), 
109 (22), 105 (100). Anal. Calcd. for C15H12N2OS: C, 67.14; H, 4.51; N, 10.44%; Found C, 67.06; H, 4.59; N, 
10.31%. 
 
1-Phenyl-3-(thiophen-2-yl)-1H-pyrazole-4-carbaldehyde, 3d: Obtained from 1-phenyl-2-(1-(thiophen-2-
yl)ethylidene)hydrazine (1d), as white solid in 81% yield, mp 99-102 ºC. IR (Nujol, γ cm-1): 1724 (s) (C=O str), 
1615 (m) (C=N str). 1H NMR (CDCl3): δ 7.466-7.782 (m, 8H, Ar-H, 5m ring-H), 8.188 (s, 1H, C5-H), 9.923 (s, 1H, 
CHO). 13C NMR (CDCl3): δ 114.19 (1C, C-4), 118.40 (2C), 126.70 (1C), 127.66 (1C), 128.10 (1C), 128.80 (1C), 
129.10 (1C), 129.34 (2C), 130.22 (1C, C-5), 137.20 (1C, C-3), 138.84 (1C), 139.26 (1C), 184.20 (1C, C=O). MS: 
m/z 255 (MH+, 10), 254 (M+, 41), 226 (40), 135 (39), 109 (20), 91 (100). Anal. Calcd. for C14H10N2OS: C, 66.12; H, 
3.96; N, 11.02%; Found C, 66.01; H, 3.86; N, 11.09%. 
 
1-(4-Chlorophenyl)-3-(thiophen-2-yl)-1H-pyrazole-4-carbaldehyde, 3e: Obtained from (E)-1-(4-chlorophenyl)-2-
(1-(thiophen-2-yl)ethylidene)hydrazine (1e), as white solid in 91% yield, mp 136-138 ºC. IR (Nujol, γ cm-1): 1736 
(s) (C=O str), 1622 (m) (C=N str). 1H NMR (CDCl3): δ 7.103-7.255 (m, 3H, 5m ring), 7.408 (d, 2H, Ar-H), 7.515 (d, 
2H, Ar-H), 8.446 (s, 1H, C5-H), 9.980 (s, 1H, CHO). 13C NMR (CDCl3): δ 115.10 (1C, C-4), 118.20 (2C), 127.92 
(1C), 128.12 (1C), 129.10 (2C), 129.30 (1C), 130.80 (1C), 131.62 (1C, C-5), 135.46 (1C, C-3), 138.00 (1C), 139.20 
(1C), 183.94 (1C, C=O). MS: m/z 290 (M+, 37Cl, 11), 288 (M+, 35Cl, 34), 262 (M+, 37Cl, 14), 260 (M+, 35Cl, 45), 226 
(40), 135 (45), 125 (100), 109 (20). Anal. Calcd. for C14H9ClN2OS: C, 58.23; H, 3.14; N, 9.70%; Found C, 58.32; H, 
3.28; N, 9.58%. 
 
1-(4-Fluorophenyl)-3-(thiophen-2-yl)-1H-pyrazole-4-carbaldehyde, 3f: Obtained from (E)-1-(4-fluorophenyl)-2-
(1-(thiophen-2-yl)ethylidene)hydrazine (1f), as white solid in 89% yield, mp 88-90 ºC. IR (Nujol, γ cm-1): 1738 (s) 
(C=O str), 1625 (m) (C=N str). 1H NMR (CDCl3): δ 7.166-7.323 (m, 3H, 5m ring), 7.426 (d, 2H, Ar-H), 7.584 (d, 
2H, Ar-H), 8.507 (s, 1H, C5-H), 10.100 (s, 1H, CHO). 13C NMR (CDCl3): δ 114.12 (1C, C-4), 116.10 (2C), 118.24 
(2C), 127.23 (1C), 127.98 (1C), 128.30 (1C), 131.72 (1C, C-5), 135.60 (1C), 135.94 (1C, C-3), 138.61 (1C), 158.20 
(1C), 184.10 (1C, C=O). Anal. Calcd. for C14H9FN2OS: C, 61.75; H, 3.33; N, 10.29%; Found C, 61.62; H, 3.42; N, 
10.20%. 
 
1-(4-Nitrophenyl)-3-(thiophen-2-yl)-1H-pyrazole-4-carbaldehyde, 3g: Obtained from (E)-1-(4-nitrophenyl)-2-(1-
(thiophen-2-yl)ethylidene)hydrazine (1g), as white solid in 90% yield, mp 172-173 ºC. IR (Nujol, γ cm-1): 1720 (s) 
(C=O str), 1610 (m) (C=N str). 1H NMR (CDCl3): δ 7.186-7.368 (m, 3H, 5m ring), 8.129 (d, 2H, Ar-H), 8.283 (d, 
2H, Ar-H), 8.364 (s, 1H, C5-H), 10.031 (s, 1H, CHO). 13C NMR (CDCl3): δ 114.84 (1C, C-4), 117.76 (2C), 122.30 
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(2C), 127.46 (1C), 128.00 (1C), 128.20 (1C), 131.14 (1C, C-5), 135.56 (1C, C-3), 138.40 (1C), 144.10 (1C), 146.22 
(1C), 184.34 (1C, C=O). Anal. Calcd. for C14H9N3O3S: C, 56.18; H, 3.03; N, 14.04%; Found C, 56.11; H, 3.16; N, 
14.13%. 
 
In IR spectra, the compounds 3(a-g) showed a strong IR absorption bands in the region  1738-1720 cm-1 for 
aldehyde C=O stretching and a medium absorption bands in the region 1625-1610 cm-1 for C=N (str) of the newly 
formed five membered ring. The absorption bands expected due to N-H (str) of =N-N-H- group of the precursors 
hydrazones in the region 3280-3150 cm-1 were found absent. These results support the formation of products. In 1H 
NMR spectra, the compounds 3(a-g) showed a consistent pattern signals as singlet in the region δ 8.304 -8.540 ppm. 
and δ 9.931-10.230  ppm. due to CHO proton and C5-H respectively. Further all compounds showed the signals due 
to substituent and aromatic protons at the expected region. 
 
In 13C NMR, the consistent pattern signals were observed in the region δ 163.00-166.00 ppm. showed signals due to 
carbonyl carbon in the region δ 114.00-115.00 ppm. δ 131.00-132.00 ppm. and δ 135.00-136.00 ppm. for C-4, C-5 
and C-3 atoms respectively. Further all compounds showed the signals due to substituent carbons, aromatic carbons, 
and thiophene ring carbons in the expected region. All new compounds gave significantly stable molecular ion peaks 
with a relative abundance ranging from 18-100%. The satisfactorily elemental analysis further supports structure of 
the products. 
 
Antimicrobial activity: The experimental results of antibacterial activity of the synthesized compounds 2(a-g) and 
3(a-g) tested against different bacterium were summarized in fig-1.  
 
 
 
The antibacterial activity of the synthesized compounds 2(a-g) and 3(a-g) tested against different bacteria showed 
varied antibacterial activity against the tested organisms.  
 
From the experimental results, it is observed that the compounds 2(a-g) exhibited relatively poorer activity 
compared to their formylpyrazole analogues 3(a-g). The compounds 2e and 3e showed excellent antibacterial 
activity in comparison with the standard streptomycin, this was attributed to the presence of chloro substitution.  On 
the other hand, the compounds 2g and 3g having the strong electron withdrawing nitro substitution in the aromatic 
ring found to be less active against all the organisms tested. 
 
The compound 3f having fluoro substitution in the aromatic ring exhibited greater activity, and the compounds 3a, 
3b and 3c exhibited remarkable activity, while the compound 3d  found moderately active against all the tested 
organisms. However; compared activity of these compounds with the corresponding formohydrazides 2a, 2b, 2c, 2d 
and 2f showed relatively lesser activity of latter.  
 
The experimental results of antifungal activity of the synthesized compounds 2(a-g) and 3(a-g) tested against 
different fungi strains were summarized in fig-2.  
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The results of antifungal activity of the synthesized compounds 2(a-g) and 3(a-g) tested against different fungal 
species revealed that, all the synthesized compounds showed moderate to good activity against the tested organisms.  
But the compounds 2f, 2g and 3f, 3g having nitro substitution exhibited least activity. The compound 2e and 3e 
showed remarkable antifungal activity in comparison with the standard nystatin against the tested organisms, this 
might be due to the presence of chloro substitution in the benzene ring. While the compound 3d having no 
substitution in the benzene ring exhibited greater activity against all the fungi species tested. The compounds 2a, 2b, 
2c and 2d showed moderate activity against the tested species. While the compounds 3a, 3b and 3c showed 
promising activity.   
 
CONCLUSION 
 
The easy procedure for the synthesis of the series of formohydrazides and formylpyrazoles by a controlled 
Vilsmeier-Haack reaction, the efficacy of synthesized molecules as antimicrobial agents validates the significance of 
this study.  Among the series of the compounds reported, 1-Phenyl-3-(thiophen-2-yl)-1H-pyrazole-4-carbaldehyde 
and 1-(4-Chlorophenyl)-3-(thiophen-2-yl)-1H-pyrazole-4-carbaldehyde acts as potential antifungal and antibacterial 
agents. 
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